M
Martine Guibourdenche
Researcher at Pasteur Institute
Publications - 15
Citations - 1099
Martine Guibourdenche is an academic researcher from Pasteur Institute. The author has contributed to research in topics: Neisseria meningitidis & Neisseria. The author has an hindex of 13, co-authored 15 publications receiving 961 citations.
Papers
More filters
Journal ArticleDOI
Supplement 2003-2007 (No. 47) to the White-Kauffmann-Le Minor scheme.
Martine Guibourdenche,Peter Roggentin,Matthew Mikoleit,Patricia I. Fields,Jochen Bockemühl,Patrick A. D. Grimont,François-Xavier Weill +6 more
TL;DR: This supplement (no. 48) of the White-Kauffmann-Le Minor scheme reports on the characterization of 63 new Salmonella serovars and 25 new variants of previously described Salmonellas recognized by the WHO Collaborating Centre for Reference and Research on Salmonello between 2008 and 2010.
Journal ArticleDOI
CRISPR typing and subtyping for improved laboratory surveillance of Salmonella infections.
Laetitia Fabre,Jian Zhang,Ghislaine Guigon,Simon Le Hello,Véronique Guibert,Marie Accou-Demartin,Saïana de Romans,Catherine Lim,Chrystelle Roux,Virginie Passet,Laure Diancourt,Martine Guibourdenche,Sylvie Issenhuth-Jeanjean,Mark Achtman,Sylvain Brisse,Christophe Sola,François-Xavier Weill +16 more
TL;DR: It was found that CRISPR polymorphism was strongly correlated with both serotype and multilocus sequence type, and spacer microevolution discriminated between subtypes within prevalent serotypes, making it possible to carry out typing and subtyping in a single step.
Journal ArticleDOI
High-Level Chloramphenicol Resistance in Neisseria meningitidis
TL;DR: The high-level chloramphenicol resistance that is described in N. meningitidis isolates is of great concern, since in developing countries, chlorampshenicol given intramuscularly is the standard therapy for meningococcal meningitis.
Journal ArticleDOI
Neisseria spp. and AIDS.
TL;DR: Neisseria meningitidis from various serogroups and two commensal neisseriae (N. sicca and N. perflava) were isolated from 15 patients at various stages of human immunodeficiency virus infection in this clinical and bacteriological study.
Journal ArticleDOI
Production of polyclonal and monoclonal antibodies against group A, B, and C capsular polysaccharides of Neisseria meningitidis and preparation of latex reagents.
Faridabano Nato,J. C. Mazie,Jean-Michel Fournier,B Slizewicz,N Sagot,Martine Guibourdenche,D. Postic,Jean-Yves Riou +7 more
TL;DR: Polyclonal and monoclonal antibodies against capsular polysaccharides of Neisseria meningitidis serogroups A, B, and C were produced in order to develop immunological reagents allowing both the detection of soluble antigens during meningococcal meningitis and antigenic serogrouping of N. mening itidis cultures.